How Can We Reach the Target of Glucose Control in Type 1 Diabetes?

Overview

Journal J Diabetes

Specialty Endocrinology

Date 2023 May 22

PMID 37211953

Authors

Zachary Bloomgarden

Affiliations

Soon will be listed here.

References

Horton W, Snell-Bergeon J . Hemoglobin A1c Variability Metrics Predict Coronary Artery Calcium and Cardiovascular Events in Type 1 Diabetes: The CACTI Study. J Clin Endocrinol Metab. 2023; 108(7):e444-e449. PMC: 10271220. DOI: 10.1210/clinem/dgad019. View

Wadwa R, Reed Z, Buckingham B, DeBoer M, Ekhlaspour L, Forlenza G . Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes. N Engl J Med. 2023; 388(11):991-1001. PMC: 10082994. DOI: 10.1056/NEJMoa2210834. View

Yapanis M, James S, Craig M, ONeal D, Ekinci E . Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring. J Clin Endocrinol Metab. 2022; 107(6):e2221-e2236. PMC: 9113815. DOI: 10.1210/clinem/dgac034. View

Nanayakkara N, Sharifi A, Burren D, Elghattis Y, Jayarathna D, Cohen N . Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes. J Diabetes Sci Technol. 2023; 18(4):889-896. PMC: 11307222. DOI: 10.1177/19322968231153882. View

Agarwal S, Schechter C, Gonzalez J, Long J . Racial-Ethnic Disparities in Diabetes Technology use Among Young Adults with Type 1 Diabetes. Diabetes Technol Ther. 2020; 23(4):306-313. PMC: 7994432. DOI: 10.1089/dia.2020.0338. View

Kilpatrick E, Rigby A, Atkin S . A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care. 2008; 31(11):2198-202. PMC: 2571045. DOI: 10.2337/dc08-0864. View

Foster N, Beck R, Miller K, Clements M, Rickels M, DiMeglio L . State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther. 2019; 21(2):66-72. PMC: 7061293. DOI: 10.1089/dia.2018.0384. View

Ly T, Keenan D, Roy A, Han J, Grosman B, Cantwell M . Automated Overnight Closed-Loop Control Using a Proportional-Integral-Derivative Algorithm with Insulin Feedback in Children and Adolescents with Type 1 Diabetes at Diabetes Camp. Diabetes Technol Ther. 2016; 18(6):377-84. DOI: 10.1089/dia.2015.0431. View

Sherr J, Buckingham B, Forlenza G, Galderisi A, Ekhlaspour L, Wadwa R . Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions. Diabetes Technol Ther. 2019; 22(3):174-184. PMC: 7047109. DOI: 10.1089/dia.2019.0286. View

10.

Wilson D, Xing D, Beck R, Block J, Bode B, Fox L . Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Care. 2011; 34(3):540-4. PMC: 3041177. DOI: 10.2337/dc10-1054. View

11.

Bequette B . Challenges and Recent Progress in the Development of a Closed-loop Artificial Pancreas. Annu Rev Control. 2012; 36(2):255-266. PMC: 3501007. DOI: 10.1016/j.arcontrol.2012.09.007. View

12.

Karges B, Tittel S, Bey A, Freiberg C, Klinkert C, Kordonouri O . Continuous glucose monitoring versus blood glucose monitoring for risk of severe hypoglycaemia and diabetic ketoacidosis in children, adolescents, and young adults with type 1 diabetes: a population-based study. Lancet Diabetes Endocrinol. 2023; 11(5):314-323. DOI: 10.1016/S2213-8587(23)00061-X. View

13.

Grassi B, Gomez A, Calliari L, Franco D, Raggio M, Riera F . Real-world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system. Diabetes Obes Metab. 2023; 25(6):1688-1697. DOI: 10.1111/dom.15023. View

14.

Rohlfing C, Wiedmeyer H, Little R, England J, Tennill A, Goldstein D . Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care. 2002; 25(2):275-8. DOI: 10.2337/diacare.25.2.275. View

15.

Nattero-Chavez L, Lecumberri Pascual E, de La Calle E, Bayona Cebada A, Ruiz T, Quintero Tobar A . Switching to an advanced hybrid closed-loop system in real-world practice improves hypoglycemia awareness and metabolic control in adults with type 1 diabetes, particularly in those with impaired perception of hypoglycemia symptoms. Diabetes Res Clin Pract. 2023; 199:110627. DOI: 10.1016/j.diabres.2023.110627. View

16.

Pintaudi B, Gironi I, Meneghini E, Conti M, Guidoni C, Di Vieste G . Advanced hybrid closed loop system use in elderly with type 1 diabetes: Effectiveness and safety in a prospective, observational, 1-year follow-up real-world study. Diabetes Obes Metab. 2023; 25(7):2034-2037. DOI: 10.1111/dom.15055. View

17.

Teo E, Hassan N, Tam W, Koh S . Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis. Diabetologia. 2022; 65(4):604-619. DOI: 10.1007/s00125-021-05648-4. View

18.

Asadi S, Nekoukar V . Adaptive fuzzy integral sliding mode control of blood glucose level in patients with type 1 diabetes: In silico studies. Math Biosci. 2018; 305:122-132. DOI: 10.1016/j.mbs.2018.09.006. View

19.

Virk S, Donaghue K, Cho Y, Benitez-Aguirre P, Hing S, Pryke A . Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes. J Clin Endocrinol Metab. 2016; 101(9):3257-63. DOI: 10.1210/jc.2015-3604. View

20.

van den Boom L, Auzanneau M, Woelfle J, Sindichakis M, Herbst A, Meraner D . Use of Continuous Glucose Monitoring in Pump Therapy Sensor Augmented Pump or Automated Insulin Delivery in Different Age Groups (0.5 to <26 Years) With Type 1 Diabetes From 2018 to 2021: Analysis of the German/Austrian/Swiss/Luxemburg Diabetes.... J Diabetes Sci Technol. 2023; 18(5):1122-1131. PMC: 11418416. DOI: 10.1177/19322968231156601. View